GlaxoSmithKline plc Company Profile (LON:GSK)

Analyst Ratings

Consensus Ratings for GlaxoSmithKline plc (LON:GSK) (?)
Ratings Breakdown: 2 Sell Rating(s), 18 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Hold (Score: 2.19)
Consensus Price Target: GBX 1,620.29

Analysts' Ratings History for GlaxoSmithKline plc (LON:GSK)
Show:
DateFirmActionRatingPrice TargetActions
7/19/2016Shore CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016BNP ParibasSet Price TargetNeutralGBX 1,530View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Credit Suisse Group AGReiterated RatingNeutralGBX 1,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Jefferies GroupUpgradeBuyGBX 1,650 -> GBX 2,000View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016Goldman Sachs Group Inc.Reiterated RatingBuyGBX 1,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,470 -> GBX 1,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2016Morgan StanleyBoost Price TargetEqual weightGBX 1,500 -> GBX 1,650View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2016Berenberg BankSet Price TargetNeutralGBX 1,785View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2016Canaccord GenuityReiterated RatingHoldGBX 1,785View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/4/2016Deutsche Bank AGBoost Price TargetHoldGBX 1,540 -> GBX 1,700View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2016Citigroup Inc.Reiterated RatingBuyGBX 1,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Beaufort SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Barclays PLCBoost Price TargetOverweightGBX 1,650 -> GBX 1,670View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Independent Research GmbHSet Price TargetNeutralGBX 1,550View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016HSBCBoost Price TargetBuyGBX 1,800 -> GBX 1,865View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Societe GeneraleReiterated RatingSellGBX 1,300View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Sanford C. BernsteinSet Price TargetNeutralGBX 1,496View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016Liberum CapitalReiterated RatingHoldGBX 1,350View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016AlphaValueReiterated RatingAddGBX 1,536View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2016Baader BankReiterated RatingHoldGBX 1,530View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016Leerink SwannReiterated RatingMarket PerformGBX 1,565View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Bryan, Garnier & CoUpgradeBuyGBX 1,635View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016NatixisReiterated RatingNeutralGBX 1,470View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015JP Morgan CazenoveReiterated RatingNeutralGBX 1,370View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Oddo SecuritiesReiterated RatingReduceGBX 1,360View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/5/2015Kepler Capital MarketsReiterated RatingHoldGBX 1,540View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/7/2015Bank of America Corp.UpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Cenkos Securities LtdReiterated RatingBuyGBX 1,643View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Charles StanleyReiterated RatingaccumulateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2014KillikReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for GlaxoSmithKline plc (LON:GSK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/27/2016$20.95N/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GlaxoSmithKline plc (LON:GSK)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for GlaxoSmithKline plc (LON:GSK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
4/27/2016GBX 191.28%5/12/20165/12/20167/14/2016Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015GBX 191.34%11/12/201511/12/20151/14/2016Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015GBX 201.34%2/18/20162/18/20164/14/2016Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015GBX 191.38%8/13/20158/13/201510/1/2015Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015GBX 191.25%5/14/20155/14/20157/9/2015Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015GBX 231.56%2/19/20152/19/20154/9/2015Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014GBX 191.37%11/6/201411/6/20141/8/2015Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014GBX 191.28%8/6/20148/6/201410/2/2014Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014GBX 191.17%5/14/20145/14/20147/10/2014Tweet This Announcement  Share This Announcement on StockTwits
2/5/2014GBX 231.36%2/19/20142/19/20144/10/2014Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013GBX 191.15%11/13/201311/13/20131/9/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for GlaxoSmithKline plc (LON:GSK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/11/2016Witty,Sir Andrew PInsiderBuy7GBX 1,671£116.97Tweet This Trade  Share This Trade on StockTwits
7/8/2016Slaoui,MoncefInsiderBuy4GBX 2,169GBX 8,676Tweet This Trade  Share This Trade on StockTwits
7/1/2016Cartwright,StaceyInsiderBuy461GBX 1,559£7,186.99Tweet This Trade  Share This Trade on StockTwits
6/9/2016Dingemans,SimonInsiderBuy9GBX 1,441£129.69Tweet This Trade  Share This Trade on StockTwits
5/20/2016Slaoui,MoncefInsiderBuy14GBX 2,100£294Tweet This Trade  Share This Trade on StockTwits
5/12/2016Slaoui,MoncefInsiderBuy24GBX 2,103£504.72Tweet This Trade  Share This Trade on StockTwits
5/11/2016Witty,Sir Andrew PInsiderBuy8GBX 1,476£118.08Tweet This Trade  Share This Trade on StockTwits
4/28/2016Witty,Sir Andrew PInsiderSell10,000GBX 1,475£147,500Tweet This Trade  Share This Trade on StockTwits
4/14/2016Slaoui,MoncefInsiderBuy495GBX 2,156£10,672.20Tweet This Trade  Share This Trade on StockTwits
3/31/2016Anderson,Sir RoyInsiderBuy511GBX 1,405£7,179.55Tweet This Trade  Share This Trade on StockTwits
3/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,404£126.36Tweet This Trade  Share This Trade on StockTwits
2/15/2016Dingemans,SimonInsiderSell39,987GBX 1,406£562,217.22Tweet This Trade  Share This Trade on StockTwits
2/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21Tweet This Trade  Share This Trade on StockTwits
1/28/2016Dingemans,SimonInsiderBuy684GBX 1,381£9,446.04Tweet This Trade  Share This Trade on StockTwits
1/14/2016Witty,Sir Andrew PInsiderBuy43GBX 1,369£588.67Tweet This Trade  Share This Trade on StockTwits
1/12/2016Dingemans,SimonInsiderBuy9GBX 1,359£122.31Tweet This Trade  Share This Trade on StockTwits
12/9/2015Dingemans,SimonInsiderBuy9GBX 1,325£119.25Tweet This Trade  Share This Trade on StockTwits
11/10/2015Dingemans,SimonInsiderBuy9GBX 1,366£122.94Tweet This Trade  Share This Trade on StockTwits
10/12/2015Dingemans,SimonInsiderBuy10GBX 1,307£130.70Tweet This Trade  Share This Trade on StockTwits
10/1/2015Rohner,UrsInsiderBuy525GBX 1,251£6,567.75Tweet This Trade  Share This Trade on StockTwits
9/10/2015Witty,Sir Andrew PInsiderBuy10GBX 1,318£131.80Tweet This Trade  Share This Trade on StockTwits
8/12/2015Dingemans,SimonInsiderBuy8GBX 1,443£115.44Tweet This Trade  Share This Trade on StockTwits
7/10/2015Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21Tweet This Trade  Share This Trade on StockTwits
7/1/2015Wijers,HansInsiderBuy534GBX 13.45GBX 7,182.30Tweet This Trade  Share This Trade on StockTwits
3/31/2015Sir Christopher GentInsiderBuy3,991GBX 1,566£62,499.06Tweet This Trade  Share This Trade on StockTwits
3/9/2015Moncef SlaouiInsiderSell22,274GBX 1,544£343,910.56Tweet This Trade  Share This Trade on StockTwits
2/18/2015Moncef SlaouiInsiderSell1,580GBX 1,553£24,537.40Tweet This Trade  Share This Trade on StockTwits
2/13/2015Simon DingemansInsiderSell12,605GBX 1,543.12£194,510.28Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for GlaxoSmithKline plc (LON:GSK)
DateHeadline
07/25/16 08:56 AMAnalysts Tips to Monitor: Merck & Company, Inc. (NYSE:MRK) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates
07/25/16 08:56 AMHC Stocks Judgment: GlaxoSmithKline plc (ADR) (NYSE:GSK) Perrigo Company plc Ordinary Shares (NYSE:PRGO) - share market updates (press release)
07/22/16 04:16 PMToday's Top Gainers in the Market GlaxoSmithKline plc (NYSE:GSK) from Healthcare - The Daily Leicester
07/22/16 04:16 PMAnalyst Recommended Stock: GlaxoSmithKline plc (NYSE:GSK) - News Oracle
07/22/16 07:15 AMGlaxoSmithKline PLC (NYSE:GSK) Updated Price Targets - FTSE News
07/20/16 05:44 PMAnalysts Holding Strong to their Buy Rating on: GlaxoSmithKline plc (NYSE:GSK) - TGP
07/19/16 10:26 AMApple’s ResearchKit: GlaxoSmithKline To Use Platform For Arthritis Study In First Major Clinical Trial Partnership
07/19/16 10:26 AMGlaxoSmithKline : Novartis in no rush to sell down stake on GSK consumer venture
07/19/16 10:26 AMGlaxoSmithKline plc (NYSE:GSK) Receives Approval For HPV Vaccine In China
07/18/16 04:31 PMGlaxoSmithKline and Apple Inc: Medicine Meets Technology - Business Finance News
07/18/16 04:31 PMTrader's Recap: NVIDIA Corporation (NASDAQ:NVDA), GlaxoSmithKline plc (NYSE:GSK), CR Bard Inc. (NYSE:BCR ... - KC Register
07/18/16 04:31 PMAnalyst's Checklist Stocks: Astrazeneca PLC (NYSE:AZN) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates
07/18/16 04:31 PMAnalysts Pounding the Table on Shares of GlaxoSmithKline plc (NYSE:GSK) - TGP
07/18/16 09:30 AMChina's Food and Drug Administration Approves GlaxoSmithKline's Cervarix
07/18/16 09:30 AMGlaxoSmithKline : Glaxo's ViiV Sees Positive Results In Phase IIIb Triumeq Study
07/18/16 09:30 AMChina approves use of GSK vaccine Cervarix for cervical cancer
07/18/16 07:29 AMARIA Study Shows Superior Efficacy of Triumeq(R) for Treatment-naive Women Living with HIV - [PR Newswire] - LONDON, England and DURBAN, South Africa, July 18, 2016 /PRNewswire/ -- ViiV Healthcare today presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed ...
07/17/16 08:47 AMCredit Suisse Indicates Potential 7.95% Increase In Shares Of Glaxosmithkline
07/16/16 07:44 AMApple Scores GlaxoSmithKline Study in Key Test of Health Apps
07/16/16 07:44 AMGlaxoSmithKline PLC (NYSE:GSK) Given Average Recommendation of "Hold" by Analysts
07/11/16 04:24 PMGlaxoSmithKline plc (NYSE:GSK) Throws Hat In Zika Ring
07/11/16 09:02 AMStreet Analyst Viewing Shares in Positive Light: GlaxoSmithKline plc (NYSE:GSK) - Telanagana Press
07/10/16 03:57 PMGlaxoSmithKline PLC (NYSE:GSK) Broker Price Targets For The Coming Week - Fiscal Standard
07/10/16 08:45 AMA look at a High Market Cap Stock: GlaxoSmithKline plc, GSK - The Daily Leicester
07/08/16 07:15 AMWhy Brexit has doomed your pension -
07/07/16 04:26 PMGlaxoSmithKline PLC (GSK) : Analyst Rating Update - TheFounders Daily
07/06/16 04:29 PMHC Stocks in Hub: GlaxoSmithKline plc (ADR) (NYSE:GSK), CVS Health Corp (NYSE:CVS) - share market updates (press release)
07/05/16 04:13 PMGlaxoSmithKline PLC (LON:GSK) Receives Hold Rating From Deutsche Bank Analysts - Fiscal Standard
07/05/16 04:13 PMLeading stocks in today's market: GlaxoSmithKline plc (NYSE:GSK) - Twin County News
07/02/16 04:12 PMAre GlaxoSmithKline plc, Trinity Mirror plc and DJI Holdings plc today's best post-Brexit buys?
07/02/16 04:12 PMNSE reviews Indices, as UACN replaces GSK on NSE 30 Index
06/30/16 04:35 PMGlaxoSmithKline starts Phase I antibody trial
06/29/16 04:15 PMGlaxoSmithKline plc (ADR) (NYSE:GSK)'s Company Shares Decreased 2.45% After High Volatility - Engelwood Daily
06/29/16 04:15 PMTwo Buzzers within Analysts Radar: Rock Creek Pharmaceuticals, Inc. (RCPI) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates
06/29/16 04:15 PMHC Stocks in Top Row: GlaxoSmithKline plc (ADR) (NYSE:GSK), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release)
06/27/16 08:45 AMShare Update and Earnings Review for GlaxoSmithKline PLC (NYSE:GSK) - Press Telegraph
06/27/16 08:45 AMAnalyst Rating Trends to Observe: Abbott Laboratories (NYSE:ABT) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates
06/27/16 08:45 AMNext Weeks Broker Price Targets For GlaxoSmithKline PLC (NYSE:GSK) - Fiscal Standard
06/27/16 08:45 AMShares of GlaxoSmithKline PLC (NYSE:GSK) Sees Large Inflow of Net Money Flow - Trade Calls
06/25/16 04:04 PMDr. Reddy’s Laboratories, GSK end tie-up in emerging markets
06/24/16 03:00 PMUW researchers compete for $1M prize from GlaxoSmithKline with device for bladder control, sexual function -
06/24/16 11:12 AMCitigroup disclosed (LON:GSK) GlaxoSmithKline PLC, maintaining its stock price target to GBX0 today - Breaking Finance News
06/24/16 10:56 AMFTSE closes down 3.2 percent, banks and housebuilders slump - [Reuters] - The FTSE 100 index initially dived more than 8 percent at the open, and was poised to post its sharpest one-day drop since the aftermath of the Lehman Brothers collapse. The FTSE 100 clawed back ground to finish 3.2 percent lower at 6,138.69 points.
06/23/16 03:32 PMNSE index rises 3.31%, as GlaxoSmithkline, Champion, Transcorp add weight
06/23/16 03:32 PMGSK August 5th Options Begin Trading
06/23/16 01:47 PMGlaxoSmithKline Has No Cure for Sideways Action -
06/23/16 09:57 AMGAVI alliance offers matched funds for GSK malaria vaccine pilot - [Reuters] - The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline's first-generation malaria vaccine, but only if other organisations promise to match that commitment. Evidence so far on the shot, developed by the British drugmaker with financial backing from the Bill & Melinda Gates Foundation, "suggests a malaria vaccine could have a significant impact in reducing malaria mortality in Africa", but more research is needed, GAVI said. Speaking to Reuters after a board meeting in Geneva, Seth Berkley, GAVI's chief executive, said the alliance was ready "to play its part" in backing the first phase pilot studies if other funders also came forward.
06/22/16 04:25 PMGlaxoSmithKline PLC (NYSE:GSK) Analyst Rating Consensus - Trade Calls
06/22/16 03:00 AMGlaxoSmithKline plc vs Smith & Nephew plc: which is the FTSE 100’s best medical marvel? -
06/20/16 04:09 PMGlaxo's triple combo smoker's cough treatment passes phase III

Social

About GlaxoSmithKline plc

GlaxoSmithKline plc logoGlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company's segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals business develops and makes medicines to treat a range of acute and chronic diseases. The Vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across the world. The Consumer Healthcare business develops and markets products in various categories, such as Wellness, Oral health, Nutrition and Skin health. The Pharmaceuticals Research and Development (R&D) focuses on the discovery and development in various areas of research, which include human immunodeficiency virus (HIV) and infectious diseases, oncology, immuno-inflammation, respiratory and rare diseases.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: GSK
  • CUSIP:
Key Metrics:
  • Previous Close: $21.97
  • 50 Day Moving Average: $1542.32
  • 200 Day Moving Average: $1452.41
  • P/E Ratio: 131.51
  • P/E Growth: 1.87
  • Market Cap: $80.50B
  • Current Year EPS Consensus Estimate: $91.43 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: